Luna Health has completed a Series A funding round, raising $23.6m to propel the advancement of the Luna insulin patch pump.

Tandem Diabetes Care announced that the FDA cleared the company's next-generation automated insulin delivery (AID) algorithm, Control-IQ+, for adults with type 2 diabetes (T2D).

Luna is the world's smallest iCGM-compatible insulin patch pump with a first-of-its-kind fully closed-loop algorithm designed to make automated insulin delivery easier, lower cost, and accessible to ...

A cross-sectional analysis from Yale School of Medicine estimates that approximately 5.8 million adolescents and 11.1 million ...

For example, Tarumi et al implemented an EHR-integrated system to predict HbA 1C changes associated with various treatment options for T2D, effectively showcasing the practicality of AI-based ...

Researchers analysed data of 108,643 adults (median age, 41.2 years; 79.2% women) from the French NutriNet-Santé e-cohort to assess associations of main food additive mixtures with the incidence ...

Age-standardized mortality rates following ischemic HF were higher in patients with T2D than in those without diabetes (19.2 vs 15.1 and 20.4 vs 16.5 per 100 person-years in women and men ...

Researchers conducted a large-scale epidemiological study to explore the potential health benefits of high muscle strength in preventing type 2 diabetes (T2D) across varying levels of genetic risk ...